We are engaged in providing a wide array of 250 MG Lapatinib Tablets IP. It is an anti-cancer drug developed by GlaxoSmithKline. This tablet is for solid tumours such as breast and lung cancer. Apart from this, provided range is formulated with a premium quality of compound and innovative techniques. It is also useful to stop the slow spread process of cancer cells. 250 MG Lapatinib Tablets IP is an antineoplastic agent and tyrosine kinase inhibitor.
Specification
Form |
Tablet |
Packaging Size |
30 tablets |
Manufacturer |
Natco |
Packaging Type |
Bottle |
Composition |
Herduo 250mg tablets (Lapatinib 250mg tablets) |
Dose |
Lapatinib 250mg |
Brand |
Herduo |